{
  "chunk_id": "VIII_ii_1_D_9",
  "content": "/>\nVIII.ii.1.D.1.d\n.\nConsidering Long-Term Health Effects Potentially Associated With Infectious Diseases\nAs specified in\n38 CFR 3.317(d)\n, if a Veteran who is presumed SC for a disease listed in column A of the table is diagnosed with a disease in column B within the time period specified in the table (if no time period is specified, at any time), the Department of Veterans Affairs (VA) will request a medical opinion as to whether it is at least as likely as not that the condition was caused by the Veteran having had the associated disease in column A.\nNote\n:  This does not preclude a finding that other manifestations of disability or secondary conditions were caused by an infectious disease.\nColumn A – Infectious Disease\nColumn B – Associated Condition(s)\nBrucellosis\narthritis\ncardiovascular, nervous, and respiratory system infections\nchronic meningitis and mengocephalitis\ndeafness\ndemyelinating meningovascular syndromes\nepiscleritis\nfatigue, inattention, amnesia, and depression\nGuillain-Barre syndrome\nhepatic abnormalities, including granulomatous hepatitis\nmultifocal choroiditis\nmyelitis-radiculoneuritis\nnummular keratitis\npapilledema\noptic neuritis\norchioepididymitis and infections of the genitourinary system\nsensorineural hearing loss\nspondylitis\nuveitis\nCampylobacter jejuni\nGuillain-Barre syndrome if manifest within two months of the infection\nreactive arthritis if manifest within three months of the infection\nuveitis if manifest within one month of the infection\nCoxiella burnetti (Q fever)\nchronic hepatitis\nendocarditis\nosteomyelitis\npost-Q-fever chronic fatigue syndrome\nvascular infection\nMalaria\ndemyelinating polyneuropathy\nGuillain-Barre syndrome\nhematologic manifestations (particularly anemia after falciparum malaria and splenic rupture after vivax malaria)\nimmune-complex glomerulonephritis\nneurologic disease, neuropsychiatric disease, or both\nophthalmologic manifestations, particularly retinal hemorrhage and scarring\nPlasmodium falciparum\nPlasmodium malariae\nPlasmodium ovale\nPlasmodium vivax\nrenal disease, especially nephrotic syndrome\nMycobacterium tuberculosis\nactive tuberculosis\nlong-term adverse health outcomes due to irreversible tissue damage from severe forms of pulmonary and extrapulmonary tuberculosis and active tuberculosis\nNontyphoid Salmonella\nreactive arthritis if manifest within three months of the infection\nShigella\nhemolytic-uremic syndrome if manifest within one month of the infection\nreactive arthritis if manifest within three months of the infection\nVisceral leishmaniasis\ndelayed presentation of the acute clinical syndrome\npost-kala-azar dermal leishmaniasis if manifest within two years of the infection\nreactivation of visceral leishmaniasis in the context of future immunosuppression\nWest Nile virus\nvariable physical, functional, or cognitive disability\nReference\n:  For more information on requesting medical opinions in claims for infectious diseases, see\nM21-1, Part VIII, Subpart ii, 1.D.2.c\n.",
  "title": "M21-1, Part VIII, Subpart ii, Chapter 1, Section D - Presumptive Service Connection (SC) for Infectious Disease Under 38 CFR 3.317",
  "citation": "Part VIII, Subpart ii, Chapter 1, Section D",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000259721/M21-1-Part-VIII-Subpart-ii-Chapter-1-Section-D-Presumptive-Service-Connection-SC-for-Infectious-Disease-Under-38-CFR-3317",
  "updated": "",
  "scraped_at": "2025-06-16T22:56:55.328120",
  "tags": [
    "m21-1"
  ]
}